<unk> , sold under the brand name<unk> tent, is a medication used to treat cancer. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006.<unk>  was the first cancer drug simultaneously approved for two different indications. As of August 2021,<unk>  is available as a generic medicine in the US.
Sunitinib
Ceritinib
Axitinib
Gilteritinib
Abrocitinib
Erdafitinib
Oclacitinib
Upadacitinib